Tuhura BiosciencesHURA

13F holders, Q4 2024 (December 31)
27holders
1famous investor
$4.09avg. 13F price*

At the end of Q4 2024, 27 institutions reported holding Tuhura Biosciences Inc. (HURA) in their 13F filings. The largest holders were Fifth Third Bancorp ($1.9M), BlackRock, Inc. ($1.6M) and Vanguard Group Inc. ($1.5M). One famous investor held it Israel Englander (0.0% of Millennium Management's portfolio).

Company
Tuhura Biosciences Inc.
CUSIP
898920103
Latest filing quarter
Q2 2026

History

Number of 13F holders

020406080100 Q4 2024: 27Q4 2024Q1 2025: 27Q1 2025Q2 2025: 50Q2 2025Q3 2025: 70Q3 2025Q4 2025: 65Q4 2025Q1 2026: 90Q1 2026Q2 2026: 89Q2 2026

Total Exit/New Position Q4 2024

InstitutionsTotal Value
New Positions26$8.8M
Exits0$0

Ownership 27 holders

Fifth Third Bancorp 0.01% New 473,559 $1.9M
BlackRock, Inc. 0.00% New 391,307 $1.6M
Vanguard Group Inc. 0.00% New 376,319 $1.5M
Geode Capital Management, LLC 0.00% New 264,915 $1.1M
Suncoast Equity Management 0.05% New 102,997 $421K
UBS Group AG 0.00% New 93,333 $382K
Citigroup Inc. 0.00% New 65,013 $266K
Apollon Wealth Management, LLC 0.01% New 61,772 $253K
Northern Trust Corp. 0.00% New 57,248 $234K
Squarepoint Ops LLC 0.00% New 54,535 $223K
Hurlow Wealth Management Group, Inc. 0.05% New 41,444 $170K
Millennium Management 0.00% New 33,808 $138K
OMERS ADMINISTRATION Corp 0.00% New 31,400 $128K
State Street Corp. 0.00% New 23,006 $94K
Charles Schwab Investment Management Inc. 0.00% New 15,000 $61K
Bank of America Corp. 0.00% New 14,314 $59K
Jefferies Financial Group Inc. 0.00% New 13,200 $54K
Qube Research & Technologies Ltd 0.00% New 12,047 $49K
TT Capital Management LLC 0.04% — 10,000 $47K
Cyndeo Wealth Partners, LLC 0.00% New 10,627 $43K
Accent Capital Management, LLC 0.02% New 7,000 $29K
Morgan Stanley 0.00% New 4,838 $20K
Wells Fargo & Company 0.00% New 1,800 $7K
Osaic Holdings, Inc. 0.00% New 3 $12
Van Hulzen Asset Management, LLC 0.00% New 1 $5
SBI Securities Co., Ltd. 0.00% — 1 $4
Acadian Asset Management LLC 0.00% New 10 $0

"% of holder's portfolio" is HURA's weight in each manager's 13F, not the share of Tuhura Biosciences Inc. the manager owns.